ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Stockholders to Contact the Firm!Accesswire • 08/15/24
Levi & Korsinsky Reminds Shareholders of an Investigation into Actinium Pharmaceuticals, Inc. (ATNM) Regarding Potential Securities Fraud AllegationsAccesswire • 08/15/24
ATNM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm!Accesswire • 08/14/24
Actinium Pharmaceuticals Inc Investors Urged To Participate In Fraud Investigation With The Schall Law FirmAccesswire • 08/14/24
An Investigation Has Commenced on Behalf of Actinium Pharmaceuticals, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your ATNM LossesAccesswire • 08/13/24
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm!Accesswire • 08/13/24
Actinium Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ATNMAccesswire • 08/13/24
Investors Encouraged To Join The Actinium Pharmaceuticals Inc Fraud Investigation With The Schall Law FirmAccesswire • 08/13/24
Actinium Pharmaceuticals, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - ATNMAccesswire • 08/12/24
ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Shareholders to Contact the Firm!Accesswire • 08/12/24
ATNM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm!Accesswire • 08/11/24
Actinium Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ATNMAccesswire • 08/09/24
ATNM Investors Invited to Participate in Actinium Pharmaceuticals, Inc. Fraud Investigation With The Schall Law FirmAccesswire • 08/09/24
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Actinium Pharmaceuticals, Inc. (ATNM)Accesswire • 08/09/24
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm!Accesswire • 08/09/24
Shareholders that lost money on Actinium Pharmaceuticals, Inc. (ATNM) should contact Levi & Korsinsky about Securities Fraud Investigation - ATNMAccesswire • 08/09/24
Shareholder Rights Advocates at Levi & Korsinsky Investigate Actinium Pharmaceuticals, Inc. (ATNM) Regarding Possible Securities Fraud ViolationsAccesswire • 08/08/24
ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Actinium Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm!Accesswire • 08/08/24
ATNM Investors Have Opportunity to Join Actinium Pharmaceuticals, Inc. Fraud Investigation with the Schall Law FirmPRNewsWire • 08/08/24
Did Actinium Pharmaceuticals, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate– ATNMAccesswire • 08/08/24
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia TreatmentBenzinga • 08/05/24
Actinium Pharma's stock craters after FDA says Phase 3 trial of leukemia treatment not enough for BLAMarket Watch • 08/05/24
Actinium Provides Regulatory Update on Planned BLA Filing and Future Plans for Iomab-B in the U.S.PRNewsWire • 08/05/24
Actinium Expands Patent Coverage Over Iomab-ACT, its Next-Generation Targeted Radiotherapy Conditioning Agent, for Gene Edited Stem Cell-Based Therapies for Non-Malignant IndicationsPRNewsWire • 08/01/24